Literature DB >> 25948862

Natural Immunity to Ebola Virus in the Syrian Hamster Requires Antibody Responses.

Joseph Prescott1, Darryl Falzarano1, Heinz Feldmann1.   

Abstract

Most ebolaviruses can cause severe disease in humans and other primates, with high case fatality rates during human outbreaks. Although these viruses have been studied for almost 4 decades, little is know regarding the mechanisms by which they cause disease and what is important for protection or treatment after infection. Because of the sporadic nature of the outbreaks and difficulties accessing the populations affected by ebolaviruses, little is also known about what constitutes an appropriate immune response to infection in humans that survive infection. Such knowledge would allow a targeted approach to therapies. In contrast to humans, rodents are protected from disease on infection with ebolaviruses, although adapted versions of some of the viruses are lethal in mice, hamsters and guinea pigs. Using the recently described hamster model, along with T-cell depletion strategies, we show that CD4(+) T cells are required for natural immunity to Ebola virus infection and that CD4-dependent antibody responses are required for immunity in this model. Published by Oxford University Press on behalf of the Infectious Diseases Society of America 2015. This work is written by (a) US Government employee(s) and is in the public domain in the US.

Entities:  

Keywords:  Ebola virus; T cell; antibody; immune response

Mesh:

Substances:

Year:  2015        PMID: 25948862      PMCID: PMC4564546          DOI: 10.1093/infdis/jiv203

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  18 in total

1.  Defective humoral responses and extensive intravascular apoptosis are associated with fatal outcome in Ebola virus-infected patients.

Authors:  S Baize; E M Leroy; M C Georges-Courbot; M Capron; J Lansoud-Soukate; P Debré; S P Fisher-Hoch; J B McCormick; A J Georges
Journal:  Nat Med       Date:  1999-04       Impact factor: 53.440

2.  Enzyme-linked immunosorbent assay for detection of filovirus species-specific antibodies.

Authors:  Eri Nakayama; Ayaka Yokoyama; Hiroko Miyamoto; Manabu Igarashi; Noriko Kishida; Keita Matsuno; Andrea Marzi; Heinz Feldmann; Kimihito Ito; Masayuki Saijo; Ayato Takada
Journal:  Clin Vaccine Immunol       Date:  2010-09-22

3.  Protection from lethal infection is determined by innate immune responses in a mouse model of Ebola virus infection.

Authors:  Siddhartha Mahanty; Manisha Gupta; Jason Paragas; Mike Bray; Rafi Ahmed; Pierre E Rollin
Journal:  Virology       Date:  2003-08-01       Impact factor: 3.616

4.  Therapeutic intervention of Ebola virus infection in rhesus macaques with the MB-003 monoclonal antibody cocktail.

Authors:  James Pettitt; Larry Zeitlin; Do H Kim; Cara Working; Joshua C Johnson; Ognian Bohorov; Barry Bratcher; Ernie Hiatt; Steven D Hume; Ashley K Johnson; Josh Morton; Michael H Pauly; Kevin J Whaley; Michael F Ingram; Ashley Zovanyi; Megan Heinrich; Ashley Piper; Justine Zelko; Gene G Olinger
Journal:  Sci Transl Med       Date:  2013-08-21       Impact factor: 17.956

5.  The adaptive immune response does not influence hantavirus disease or persistence in the Syrian hamster.

Authors:  Joseph Prescott; David Safronetz; Elaine Haddock; Shelly Robertson; Dana Scott; Heinz Feldmann
Journal:  Immunology       Date:  2013-10       Impact factor: 7.397

6.  Induction of immune responses in mice and monkeys to Ebola virus after immunization with liposome-encapsulated irradiated Ebola virus: protection in mice requires CD4(+) T cells.

Authors:  Mangala Rao; Mike Bray; Carl R Alving; Peter Jahrling; Gary R Matyas
Journal:  J Virol       Date:  2002-09       Impact factor: 5.103

Review 7.  Filoviral immune evasion mechanisms.

Authors:  Parameshwaran Ramanan; Reed S Shabman; Craig S Brown; Gaya K Amarasinghe; Christopher F Basler; Daisy W Leung
Journal:  Viruses       Date:  2011-09-07       Impact factor: 5.048

8.  Protective efficacy of neutralizing monoclonal antibodies in a nonhuman primate model of Ebola hemorrhagic fever.

Authors:  Andrea Marzi; Reiko Yoshida; Hiroko Miyamoto; Mari Ishijima; Yasuhiko Suzuki; Megumi Higuchi; Yukie Matsuyama; Manabu Igarashi; Eri Nakayama; Makoto Kuroda; Masayuki Saijo; Friederike Feldmann; Douglas Brining; Heinz Feldmann; Ayato Takada
Journal:  PLoS One       Date:  2012-04-27       Impact factor: 3.240

9.  Effective post-exposure treatment of Ebola infection.

Authors:  Heinz Feldmann; Steven M Jones; Kathleen M Daddario-DiCaprio; Joan B Geisbert; Ute Ströher; Allen Grolla; Mike Bray; Elizabeth A Fritz; Lisa Fernando; Friederike Feldmann; Lisa E Hensley; Thomas W Geisbert
Journal:  PLoS Pathog       Date:  2007-01       Impact factor: 6.823

10.  Sustained protection against Ebola virus infection following treatment of infected nonhuman primates with ZMAb.

Authors:  Xiangguo Qiu; Jonathan Audet; Gary Wong; Lisa Fernando; Alexander Bello; Stéphane Pillet; Judie B Alimonti; Gary P Kobinger
Journal:  Sci Rep       Date:  2013-11-28       Impact factor: 4.379

View more
  6 in total

1.  Construction of a new chromosome-scale, long-read reference genome assembly for the Syrian hamster, Mesocricetus auratus.

Authors:  R Alan Harris; Muthuswamy Raveendran; Dustin T Lyfoung; Fritz J Sedlazeck; Medhat Mahmoud; Trent M Prall; Julie A Karl; Harshavardhan Doddapaneni; Qingchang Meng; Yi Han; Donna Muzny; Roger W Wiseman; David H O'Connor; Jeffrey Rogers
Journal:  Gigascience       Date:  2022-05-28       Impact factor: 7.658

2.  An immune-competent, replication-permissive Syrian Hamster glioma model for evaluating Delta-24-RGD oncolytic adenovirus.

Authors:  Lynette M Phillips; Shoudong Li; Joy Gumin; Marc Daou; Daniel Ledbetter; Jing Yang; Sanjay Singh; Brittany C Parker Kerrigan; Anwar Hossain; Ying Yuan; Candelaria Gomez-Manzano; Juan Fueyo; Frederick F Lang
Journal:  Neuro Oncol       Date:  2021-11-02       Impact factor: 13.029

3.  De novo assembly, annotation, and characterization of the whole brain transcriptome of male and female Syrian hamsters.

Authors:  Katharine E McCann; David M Sinkiewicz; Alisa Norvelle; Kim L Huhman
Journal:  Sci Rep       Date:  2017-01-10       Impact factor: 4.379

Review 4.  Syrian Hamster as an Animal Model for the Study on Infectious Diseases.

Authors:  Jinxin Miao; Louisa S Chard; Zhimin Wang; Yaohe Wang
Journal:  Front Immunol       Date:  2019-10-01       Impact factor: 7.561

5.  Syrian Hamsters as a Small Animal Model for Emerging Infectious Diseases: Advances in Immunologic Methods.

Authors:  Bryce M Warner; David Safronetz; Gary P Kobinger
Journal:  Adv Exp Med Biol       Date:  2017       Impact factor: 2.622

Review 6.  Ebolavirus: Comparison of Survivor Immunology and Animal Models in the Search for a Correlate of Protection.

Authors:  Stephanie Longet; Jack Mellors; Miles W Carroll; Tom Tipton
Journal:  Front Immunol       Date:  2021-02-19       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.